LNCARSR and nonpapillary renal cell carcinoma: Another study showed that lncARSR transported by exosomes promoted the expression of AXL and c-MET in ccRCC cells by competitively binding miR-34/miR-449, rendering ccRCC patients resistant to sunitinib [12].